A. Peter Thompson

Affiliations

  • Large Shareholder, Director at Decibel Therapeutics Inc. (DBTX), 2022-06-21
  • Large Shareholder, Director at Corvus Pharmaceuticals Inc. (CRVS), 2022-06-17
  • Director at Janux Therapeutics Inc. (JANX), 2022-06-16
  • Large Shareholder, Director at Silverback Therapeutics Inc. (SBTX), 2022-06-13
  • Large Shareholder, Director at Edgewise Therapeutics Inc. (EWTX), 2022-05-20
  • Large Shareholder, Director at Alpine Immune Sciences Inc. (ALPN), 2022-01-04
  • Large Shareholder, Director at Pmv Pharmaceuticals Inc. (PMVP), 2021-06-09
  • Large Shareholder, Director at Prevail Therapeutics Inc. (PRVL), 2021-01-26
  • Large Shareholder, Director at Synthorx Inc. (THOR), 2020-01-24
  • Director at Principia Biopharma Inc. (PRNB), 2018-09-13
  • Director at Adaptimmune Therapeutics Plc (ADAP), 2018-06-06
  • Large Shareholder, Director at Response Biomedical Corp (RBM), 2016-12-02
  • Director at Pronai Therapeutics Inc (DNAI), 2015-07-21
  • Director at Mirati Therapeutics Inc. (MRTX), 2013-07-12
  • Director at Anthera Pharmaceuticals Inc (ANTH), 2012-05-11
  • Officer, Director at Trubion Pharmaceuticals Inc (TRBN), 2009-05-26
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
EWTX $7.21 138,000 Large Shareholder, Director 13,497,456 2022-05-18 Filing
ALPN $9.40 425,531 Large Shareholder, Director 425,531 2021-09-17 Filing
ALPN $9.40 585,106 Large Shareholder, Director 3,656,061 2021-09-17 Filing
JANX $17.00 117,650 Director 282,398 2021-06-15 Filing
JANX $17.00 588,203 Director 2,760,366 2021-06-15 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
JANX $20.30 3,700 Director 231,098 2021-12-29 Filing
JANX $20.30 36,700 Director 2,258,566 2021-12-29 Filing
JANX $19.00 11,100 Director 234,798 2021-12-21 Filing
JANX $19.00 108,300 Director 2,295,266 2021-12-21 Filing
JANX $19.07 36,500 Director 245,898 2021-12-16 Filing